Eye-Drop And Lubricants Global Market Report 2025

The eye-drop and lubricants market size has grown strongly in recent years. It will grow from $20.51 billion in 2024 to $21.63 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to several factors, including a stronger driving force behind eye-drop and lubricant demand, the need for effective treatments, increased screen time, greater exposure to digital devices and lifestyles, and the rising use of contact lenses.

The eye-drop and lubricants market size is expected to see strong growth in the next few years. It will grow to $26.47 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth projected for the forecast period is driven by increasing awareness of eye health, a rising prevalence of dry eye syndrome (DES), an expanding elderly population, and a surge in allergies and environmental irritants. Key trends during this period include the adoption of digital eye health monitoring, advancements in smart delivery systems, broader applications in post-surgical recovery, and strategic partnerships.

The increasing occurrence of vision-related conditions is expected to drive the growth of the eye-drop and lubricants market in the future. Vision-related cases include medical issues or disorders that impair clear or comfortable sight. This rise is primarily fueled by longer screen time, which leads to digital eye strain and accelerates myopia development, particularly among children and young adults. Eye drops and lubricants alleviate symptoms associated with these conditions - such as dryness, irritation, and redness - by moisturizing the eyes, reducing inflammation, and stabilizing the tear film, thereby improving overall eye comfort and visual clarity. For example, in October 2024, the Royal National Institute of Blind People, a UK charity supporting those with visual impairments, projected a 29% increase in individuals with severe sight loss or blindness, from 298,000 in 2022 to 379,000 by 2035. Consequently, the growing prevalence of vision-related cases is fueling market expansion for eye drops and lubricants.

Leading companies in the eye-drop and lubricants market are prioritizing the development of innovative products, such as vitamin D3-enriched lubricating eye drops, to more effectively treat dry eye symptoms and meet the rising demand for multifunctional ocular health solutions. These vitamin D3-enriched lubricating eye drops are ophthalmic formulations that combine vitamin D3 (cholecalciferol) with moisturizing agents to not only soothe dry eyes but also offer anti-inflammatory and immune-modulating benefits. For example, in May 2024, Entod Pharmaceuticals, an Indian pharmaceutical firm, launched vitamin D3-enriched lubricating eye drops, marking a notable advancement in eye care by providing targeted relief for dry eye syndrome sufferers. This novel formulation integrates vitamin D3 into selected lubricant eye drop brands to promote ocular surface health, enhance tear film stability, and aid corneal wound healing. Available by prescription only, this product addresses the widespread vitamin D deficiency in India, which is associated with several eye conditions, including age-related macular degeneration and diabetic retinopathy.

In April 2023, Nirma Group, a chemical company based in India, acquired Stericon Pharma for an undisclosed sum. This acquisition is part of Nirma’s strategy to strengthen its footprint in the pharmaceutical industry, especially in ophthalmic products and sterile manufacturing. It complements its existing healthcare division, Aculife Healthcare, and supports the company’s broader goal of expanding and acquiring more firms within the pharma sector. Stericon Pharma, also based in India, specializes in producing sterile multipurpose contact lens cleaning solutions, eye drops, and eye lubricants.

Major players in the eye-drop and lubricants market are Bayer AG, Sanofi S.A., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Incorporated, Santen Pharmaceutical Co. Ltd., Alimera Sciences Inc., Scope Ophthalmics Ltd., Lenz Therapeutics Inc., Eyeris Vision Care Pvt. Ltd., Nicox S.A., Akums Drugs and Pharmaceuticals Ltd., Allergan plc, Jawa Pharmaceuticals Pvt. Ltd., Medtech Products Inc.

North America was the largest region in the eye-drop and lubricants market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in eye-drop and lubricants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the eye-drop and lubricants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Eye-drops and lubricants are liquid preparations applied directly to the eyes to treat different conditions or relieve discomfort. Eye-drops may contain medications designed to tackle problems such as infections, allergies, or glaucoma, whereas lubricants - commonly known as artificial tears - mainly serve to hydrate and calm dry or irritated eyes caused by environmental factors or medical issues.

The primary categories of eye drops and lubricants include antibiotics, hormones, artificial tears, and other types. Antibiotics are medications used to prevent and treat bacterial infections. They can be made in forms like liquids, ointments, gels, or sprays and are available through online stores, pharmacies, supermarkets or hypermarkets, and specialty shops. These products are used for various purposes including treating eye diseases and general eye care, and they cater to different users such as hospitals, clinics, home care providers, and eyewear centers.

The eye-drop and lubricants market research report is one of a series of new reports that provides eye-drop and lubricants market statistics, including eye-drop and lubricants industry global market size, regional shares, competitors with an eye-drop and lubricants market share, detailed eye-drop and lubricants market segments, market trends and opportunities, and any further data you may need to thrive in the eye-drop and lubricants industry. This eye-drop and lubricant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The eye-drop and lubricants market consists of sales of rewetting drops, allergy eye drops, artificial tears, redness relievers, and eye ointments and gels. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.